13 Proven Tactics to Outmaneuver Generic Drug Rivals
The truth is, the end of patent exclusivity is not the end of the story. It is the beginning of […]
13 Proven Tactics to Outmaneuver Generic Drug Rivals Read Post »
July 2024
Best Practices for Drug Patent Portfolio Management: Maximizing Value in Pharmaceutical Innovation
Introduction: Beyond the Molecule – Why Your Patent Portfolio is Your Most Valuable Asset In the high-stakes world of pharmaceutical
Benefits of Drug Patent Licensing Agreements
Introduction: Beyond the Contract – Licensing as a Strategic Imperative In the high-stakes, capital-intensive world of biopharmaceutical innovation, the journey
Benefits of Drug Patent Licensing Agreements Read Post »
The Pivotal Role of Patient Advocacy Groups in Shaping Generic Drug Development and Access
I. Executive Summary This report provides a comprehensive analysis of the evolving and increasingly vital role of Patient Advocacy Groups
Chiral Switching: Reassessing Relevance in Today’s Pharmaceutical Pricing Control Scenario
Executive Summary This report examines the contemporary relevance of chiral switching within the pharmaceutical industry, particularly in light of evolving
How to Develop a Competitive Edge in Generic Drug Development
I. Executive Summary The generic drug market stands as a cornerstone of global healthcare, fundamentally contributing to affordability and access
How to Develop a Competitive Edge in Generic Drug Development Read Post »
How to Find Key Starting Materials (KSMs) for Pharmaceutical APIs
The foundation of any successful pharmaceutical manufacturing process lies in the careful selection and management of Key Starting Materials (KSMs)
How to Find Key Starting Materials (KSMs) for Pharmaceutical APIs Read Post »
Drafting Detailed Drug Patent Claims: The Art and Science of Pharmaceutical IP Protection
Part I: The Foundation of Pharmaceutical Patent Protection Section 1: The Symbiotic Relationship Between Patents and Pharmaceutical Innovation The modern
The Chiral Switch: A Pharmaceutical Tactic to Prolong Exclusivity
Introduction: The Two-Faced Molecule—Innovation or Intellectual Property Ploy? Imagine holding your left and right hands in front of you. They
The Chiral Switch: A Pharmaceutical Tactic to Prolong Exclusivity Read Post »
